Arazoza, EA, Bowser, M, Obied, AI, CORONARY ARTERY FISTULA DIAGNOSIS BY BIPLANE TRANSESOPHAGEAL ECHOCARDIOGRAPHY, J. Amer. Soc. Echocardiography, May-June 1992, Vol. 5, p. 277-80.

RL Kirshner, PA Knight, MA Thompson, TS Antonacci, K Gardner, KM Rao, EA Arazoza. VENTRICULAR REDUCTION SURGERY AS A TREATMENT FOR IDIOPATHY DILATED CARDIOMYOPATHY, JACC, Feb. 1997, Vol. 29 Sup.A, p. 466A.

M. Berlowitz, F. Latif, S. Hankins, PV Ennezat, R. Moskowitz, S. Tandon, PC Colombo, TH Lejemtel:  “Dose Dependent Blockade of the Angiotensin II Type I (AT1) Receptor with Losartan in Normal Volunteers,” Journal of Cardiovascular Pharmacology 2001; 37(6):692-696.

P. Ennezat, M. Berlowitz, EH Sonnenblick, TH Lejemtel:  “Therapeutic Implications of Escape from Angiotensin-Converting Enzyme Inhibition in Patients with Chronic Heart Failure,” Current Cardiology Reports 2000; 2:258-262.

F. Latif, S. Tandon, R. Obeleniene, SR Hankins, M. Berlowitz, PV Ennezat, TH Lejemtel:  “Angiotensin II Type 1 Receptor Blockade with 80 and 160 mg of Valsartan in Healthy, Normotensive Subjects,” Journal of Cardiac Failure 2001; 7(3):265-268.

M. Berlowitz, V. Srinivas, B. Vakili, D. Brown:  “Short-Term Outcomes Following Angioplasty of the Left Main Coronary Artery: New York State Experience,” Albert Einstein College of Medicine (Submitted).

M. Berlowitz, P. Ennezat, F. Latif, S. Lauro, JM Hu, S. Tandon, R. Moskowitz, EH Sonnenblick, TH Lejemtel:  “Dose Dependent Blockade of the Angiotensin II Type 1 Receptor in Normal Volunteers: Incomplete and Transient Blockade by Losartan 50 mg,” Journal of the American College of Cardiology 2001; 37(2):273A.

M. Berlowitz, V. Srinivas, B. Vakili, D. Brown: “Patient Characteristics and In-Hospital Outcomes Following Angioplasty of the Left Main Coronary Artery: New York State Experience,” Journal of the American College of Cardiology 2000; 35(2):12A.

M. Berlowitz, C. Aguedelo: “Symmetric Polyarthritis and Edema in the Elderly: Clues to Polymyalgia Rheumatica?” American College of Physicians, Georgia Regional Convention Abstracts, 1996.

M. Berlowitz, A. Moreira, G. Kaplan: “A Study of the Effect of Thalidomide on Lipopolysaccharide Induced Tumor Necrosis Factor Production In Vivo,” University of Michigan Medical School Biomedical Research Abstracts, 1993.

M. Berlowitz, D. Brown:  “The Clinical Manifestations of Plaque Rupture,”  In Brown D (ed): Cardiovascular Plaque Rupture.  New York, Marcel Dekker, 2002, Chapter 8.

Dale, R.C. and Schroeder, E.T.: "Respiratory Paralysis During Treatment of Hypertension with trimetaphan camsylate", Arch. Int. Med. 136:816-818, 1976

Dale, R.C., et al: "Bronchiolitis Obliterans: Long Term Followup" New York State Journ. Med. 77:1485-88, 1977 Poe, Ortiz, Israel, Marin, Qazi, Dale & Greenblatt: "Sensitivity, Specificity and Predictive Values of Bronchoscopy in Neoplasm Metastatic to Lung", Chest 88:1985

Robert H. Poe, M.D., Robert H. Israel, M.D., Mukesh Ahluwalia, M.D. and Robert C. Dale, M.D. "Experience with Flexible Bronchoscopy in the Nonresolving Pulmonary Infiltrate", Journal of Bronchology 5:14-19, 1998.

Fitzpatrick PG, Cinquegrani MP, Vakiener AR, Baggs JG, Biddle TL, Liang C-s, and Hood WB Jr: Hemodynamic and Regional Blood Flow Response to Milrinone in Patients with Severe Congestive Heart Failure: A dose-ranging study. Am Heart J 114:97-105, 1987.

Biddle TL, Benotti JR, Creager MA, Faxon DP, Firth BG, Fitzpatrick PG, Konstam MA, Krebs C, Walton L, Kirshner RP, Jacobsen J, Luczkowec CA, Montenaro MJ, Tandon PK, Fitzpatrick S, Schwarz RP Jr: Comparison of Intravenous Milrinone and Dobutamine for Congestive Heart Failure Secondary to Either Ischemic or Dilated Cardiomyopathy. Am J Cardiol 59:1345-1350, 1987.

Marder VJ, Rothbard RL, Fitzpatrick PG, Francis CS, Norry EC: Dose-ranging studies of anisoylated plasminogen streptokinase activator complex: Studies in healthy volunteers and in patients with acute myocardial infarction. Drugs 33 (Suppl. 3): 124-132, 1987.

Sorensen SB, Hackworthy RA, Fitzpatrick PG, Barry WH, Menlove RL, Anderson JL (for the APSAC Multicenter Investigators): Acute Coronary Occlusion and Reperfusion: Reliability of angiographic classification and grading. Drugs 33 (Suppl. 3): 163-168, 1987.

Anderson JL, Rothbard RL, Hackworthy RA, Sorensen SG, Fitzpatrick PG, Dahl CF, Hagan AD, Browne KF, Symkoviak GP, Menlove RL, Barry WH, Eckerson HW, Marder VJ (for the APSAC Multicenter Investigators): Multicenter Reperfusion Trial of Intravenous Anisoylated Plasminogen Streptokinase Activator Complex (APSAC) in Acute Myocardial Infarction: Controlled comparison with intracoronary streptokinase. J Am Col Cardiol 11:1153-1163, 1988.

Hackworthy RA, Sorensen SG, Fitzpatrick PG, Barry WH, Menlove RL, Rothbard RL, Anderson JL: Dependence of Assessment of Coronary Artery Reperfusion on Angiographic Criteria and Interobserver Variability: Implications for comparisons among clinical trials. Am J Cardiol 62:538-543, 1988.

Hackworthy RA, Sorensen SG, Fitzpatrick PG, Barry WH, Menlove RL, Rothbard RL, Anderson JL: Effect of Reperfusion on Electrocardiographic and Enzymatic Infarct Size: Results of a randomized multicenter study of intravenous anisoylated plasminogen streptokinaseactivator complex (APSAC) versus intracoronary streptokinase in acute myocardial infarction. Am Heart J 116:903, 1988.

Brenner B, Francis CW, Fitzpatrick PG, Rothbard RL, Cox C, Hackworthy RA, Anderson JL, Sorensen SG, Marder VJ: Relation of plasma D-dimer concentrations to coronary artery reperfusion before and after thrombolytic treatment in patients with acute myocardial infarction. Am J Cardiol 63:1179-1184, 1989.

Rothbard RL, Anderson JL, Hackworthy RA, Sorensen SG, Fitzpatrick PG, Marder VJ. Tolerance and complications in a multicenter trial of intravenous APSAC and intracoronary streptokinase in acute myocardial infarction. Clin Cardiol 13:V11-14, 1990.

Sorensen SG, Hackworthy RA, Fitzpatrick PG, Menlove R, Anderson JL. Variability of thrombolytic coronary reperfusion: angiographic study of streptokinase andanistreplase. Clin Cardiol 13:V15-19, 1990.

The SOLVD Investigators. Studies of left ventricular dysfunction (SOLVD) - Rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. Am J Cardiol 66:315-322, 1990.

The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325:293-302.

Anderson JL, Sorensen SG, Moreno FL, Hackworthy RA, Browne KF, Dale HT, Leya F, Dangoisse V, Eckerson HW, Marder VJ, and the TEAM-2 Study Investigators. Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. Circulation 1991; 83:126-140.

Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano JA, Shannon J, Tandon PK, DeMets DL for the PROMISE Study Research Group. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991; 325:1468-75.

Karagounis L, Sorensen SG, Menlove RL, Moreno F, Anderson JL, for the TEAM-2 Investigators. Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly parent artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. J Am Coll Cardiol 1992; 19:1-10.

Reisner SA, Ong LS, Fitzpatrick PG, Lichtenberg GS, Sullebarger JT, Allen MN, Meltzer RS. Evaluation of coronary flow reserve using myocardial contrast echocardiography in humans. European Heart J 1992; 13:389-24.

Marder VJ, Shortell CK, Fitzpatrick PG, Kim C, Oxley D. An animal model of fibrinolytic bleeding based on the rebleed phenomenon: application to a study of vulnerability of hemostatic plugs of different age. Thrombosis Research 1992; 67:31-40.

Anderson JL, Becker LC, Sorensen SG, Karagounis LA, Browne KF, Shah PK, Morris DC, Fintel DJ, Mueller HS, Ross AM, Hall SM, Askins JC, Doorey AJ, Grines CL, Moreno FL, Marder VJ, for the TEAM-3 Investigators. Anistreplase versus atleplase in acute myocardial infarction: comparative effects on left ventricular function, morbidity and 1-day coronary artery patency. J Am Coll Cardiol 1992; 20:753-766.

The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327:685-91.

Anderson JL, Karagounic LA, Becker LC, Sorensen SG, Menlove RL, for the TEAM-3 Investigators. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 study. Circulation 1993; 87:1829-1839.

Fitzpatrick PG, Nanda NC, Harris JP, Alexson C, Manning JA: Two-dimensional echocardiographic identifiaction of multiple cardiac tumors in a newborn. Ultrasound in Med and Biol 8: 695, 1982.

Fritz T, Richeson JF, Fitzpatrick PG, Wilson G:P Venous obstruction: A potential complication of permanent pacemakers. Chest 83:534, 1983.

Kwong TC, Fitzpatrick PG, Rothbard RL: Serum creatine kinase activity following thrombolysis in acute MI. Selected Topics in Clin Enzymology 2: 411, 1984.

Kwong TC, Fitzpatrick PG, Rothbard RL: Activities of some enzymes in serum after therapy with intracoronary streptokinase in acute MI. ClinChem 30: 731-734, 1985.

Rothbard RL, Fitzpatrick PG, Francis CS, Caton DM, Hood WB, Marder VJ: Relationship of the lytic state to successful reperfusion with standard and low dose intracoronary streptokinase. Circulation 71: 562-570, 1985.

Marder VJ, Rothbard RL, Fitzpatrick PG, Francis CW: Rapid lysis of coronary thrombi with anisoylated plasminogen: streptokinase activator complex. Treatment by bolus intravenous injection. Ann Int Med 104: 304, 1986.

The Esmolol Research Group: Intravenous esmolol for the treatment of supreventricular tachyarrhythmia: Results of a multicenter, baseline-controlled safety and efficacy study in 160 patients. Am Heart J 112:498, 1986.

Kaplan KL, Fitzpatrick PG, Cox C, Shamas N, Marder V. Treatment of Women and Elderly with Acute Myocardial Infarction. Submitted for publication.

Gage L; Healing By the Fundamentals (letter); New England Journal of Medicine 1984; 311: 1637-9.

Eichelberger, J., Gage, L.; Echocardiographic Assesment of Epicardial Defibrillator Patch Electrodes; PACE 1995;18(4), part 1; 689-96.

Gacioch GM and Topol EJ: Sudden, paradoxical clinical deterioration during angioplasty of the occluded right coronary artery in acute myocardial infarction. J Am Coil Cardiol 1989;14:1202-1209.

Clemmensen P, Bates ER, Califf RM, Hlatky M, Aronson L, George BS, Lee KL, Keriakes DJ, Gacioch GM, Berrios E, Topol EJ and the TAMI Study Group. Complete atrioventricular block complicating acute inferior myocardial infarction treated with reperfusion therapy. Am J Cardiol 1991;67:225-230.

Stewart RE, Schwaiger M, Molina E, Popma JP, Gacioch GM, Kalis M, Squicciarini S, Al-Aouar ZR, Schork A, Kuhl DE. Comparison of Rubidium-82 and Thallium-201 SPECT imaging for the detection of coronary artery disease. Am J Cardiol 1991;67:1303-1310

Gacioch GM, Ellis SG, Lee L, Bates ER, Kirsh M, Walton JA, Topol EJ. Cardiogenic shock complicating acute myocardial infarction: the use of coronary angioplasty and the integration of the new support devices. J Am Coll Cardiol 1992;19:647-53.

Altavela JL, Haas CE, Nowak DR, Powers J and Gacioch GM. Clinical response to intravenous nitroglycerin infused through polyethylene or polyvinal chloride tubing. Am J Hosp Pharm 1994;51:490-4.

The EPIC Investigators. Use of a monocional antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61

The EPIC Investigators. Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: Results at six months. Lancet 1994;343:881-86.

Wall TC, Topol EJ, Califf RM, Blankenship J, Talley JD, Tannenbaum M, Schwaiger M, Gacioch GM, Cohen MD, Sanz M, Leimberger JD. Intravenous Fluosol in the treatment of acute myocardial infarction: Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial. Circulation 1994;90:114-120.

GUSTO IIa Investigators. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. Circulation 1994;90:1631-37.

E. Magnus Ohman, MD; Neal S. Kleiman, MD; Gerald Gacioch, MD; Seth J. Worley, MD; Frank I. Navetta, MD; J. David Talley, MD; H. Vernon Anderson, MD; Stephen G. Ellis, MD; Mark D. Cohen, MD; Douglas Spriggs, MD; Michael Miller, MD; Dean Kereiakes, MD; Steven Yakubov, MD; Michael M. Kitt, MD; Kristina N. Sigmon, MA; Robert M. Califf, MD; Mitchell W. Krucoff, MD; Eric J. Topol, MD; for the IMPACT-AMI Investigators. Combined Accelerated Tissue-Plasminogen Activator and Platelet Glycoprotein IIb/IIIa Integrin Receptor Blockade With Integrilin in Acute Myocardial Infarction: Results of a Randomized, Placebo-Controlled, Dose-Ranging Trial. Circulation 1997;95:846-54.

IMPACT-II Investigators. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention. Lancet 1997;349:1422-28.

Coumadin Aspirin Reinfarction Study (CARS) Investigators. Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Lancet 1997;350:389-396.

EPILOG Investigators. Platelet Glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-96.

GUSTO Iib Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997;336:1621-8.

2nd SYMPHONY Substudy Investigator. A Phase II Mulit-center, international, Randomized, Double-Blind, Aspirin-Controlled Trial to Evaluate the safety and efficacy of Two Regimens with Xubix^TM (Sibrafiban; Ro 48/3657), an Oral Platelet Glycoprotein IIb/IIIaReceptor Antagonist, as Therapy for the Long Term Prevention of Secondary Vascular Events in Patients After an Acute Coronary Syndrome. 1998

Gacioch GM and Topol EJ: Paradoxical, sudden clinical deterioration after reperfusion of the right coronary artery: A hazard of primary or rescue coronary angioplasty for myocardial infarction. Presented at the American Heart Association, November, 1988, Washington, D.C. Circulation 1988;78(suppl II):111.

Aaronson KD, Gacioch GM, Topol EJ, Schwaiger M: Comparison of dipyridamole 201 TI-SPECT with exercise RNV for the detection of jeopardized myocardium following thrombolytic therapy for acute myocardial infarction. Presented at the Society of Nuclear Medicine Annual Meeting, June , 1989, St. Louis. J Nuc Med 1989;30:862.

Kalus ME, Stewart RE, Gacioch GM, Squicciarini SA, Hutchins GD, Kuhl DE, Schwaiger M: Comparison of RB-82 and TI-201 SPECT for detection of regional coronary artery disease. Presented at the Society of Nuclear Medicine Annual Meeting, June, 1989, St. Louis. J Nuc Med 1989;30:829-30.

Gacioch GM and Topol EJ: Frontiers in cardiogenic shock: Integration of angioplasty and new support devices. Presented at the 1989 American Heart Association Annual Meeting, New Orleans. Circulation 1989;80(suppl II):II-624.

Gacioch GM for the TAMI Study Group: Rescue angioplasty for failed thrombolytic therapy: the TAMI I-IV experience. Presented at the 1989 American Heart Association Annual Meeting, New Orleans. Circulation 1989;80(suppl II):II-625.

Stewart R, Kalus M, Molina E, Gacioch G, Squicciarini S, Hutchins G, Kuhl D, Shcwaiger M. Rubidium-82 PET versus Thallium-201 SPECT for the diagnosis of coronary artery disease. Presented at the 1989 American Heart Association Annual Meeting, New Orleans. Circulation 1989;80(Suppl II):II-209.

Stewart R, Gacioch GM, Popma JJ, Kalus M, Molina E, Squicciarini S, Kuhl DE, Schwaiger M. Discrepancy between Thallium-201 redistribution and Rubidium-82 flow imaging. Presented at the 1990 American College of Cardiology Annual Meeting, New Orleans. J Am Coll Cardiol 1990;15(suppl A):249A

Wall TC, Topol EJ, Califf RM, Blankenship J, Talley D, Tannenbaum M, Gacioch GM, Cohen M, Sanz M, Leimberger J, for the TAMI 9 Study Group. TAMI 9: Preliminary report of a prospective randomized trial of intravenous Fluosol in acute myocardial infarction. Presented at the 1992 American Heart Association Annual Meeting, New Orleans.

Altavela IL, Haas CE, Nowak DR, Powers JM, Gacioch GM. Comparison of polyethylene and polyvinyl chloride sets for the administration of intravenous nitroglycerin to treat ischemic heart disease. Presented at 1993 American College of Clinical Pharmacology Annual Meeting, Reno. Pharmacotherapy 1993;13(3):275.

Ohman EM, Kleinman NS, Talley JD, Gacioch GM, et al. Simultaneous platelet glycoprotein IIb/IIIa Integrin blockade with accelerated tissue plasminogen activator in acute myocardial infarction. Presented at the 1994 American Heart Association Annual Meeting, Dallas.

Hamer M, Wharton J, Page R. Utility of transtelephonic ECG monitoring in evaluating discharges from a third generation implantable cardioverter defibrillator. J Electrocardiol 1993:26(3);235-238.

Hamer M. New strategies in the diagnosis and management of the critically ill patient with cardiopulmonary disease. Resident and Staff Physician March 1993,6-11.

Hamer M, Clair W, Wilkinson W, Greenfield R, Pritchett E, Page R. Evaluation of outpatients experiencing implantable cardioverter defibrillator shocks with minimal symptoms. PACE 1994:17(1);938-943.

Hamer M, Blumenthal J, McCarthy E, Phillips B, Pritchett E. Quality of life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia. Am J Cardiol 1994:74;826-829.

Sanders W, Sorrentino R, Greenfield R, Shenasa H, Hamer M, Wharton M. Catheter ablation of sinoatrial node reentrant tachycardia. J Am Coll Cardiol 1994:23;926-934.

Hamer M, Wilkinson W, Clair W, Page R, McCarthy E, Pritchett E. Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardia. J Am Coll Cardiol: 1995:25(5);984-988.

Hamer M, Wilkinson W, McCarthy E, Page R, Pritchett E. Heart rate during spontaneous and induced paroxysmal supraventricular tachycardia. (accepted for publication by PACE, September 1995)

Bengston J, Longabaugh J, Hamer M. Myocardial ischemia. In Dantzker D, MacIntyre N, Bakow E, eds: Comprehensive Respiratory Care. W.B. Saunders, Philadelphia 1995. Ch 31, p 603-610.

Hamer M, Ideker R, Wharton J. Rhythm Detection and Analysis. In Levine R, Fromm R, eds: Critical Care Monitoring. Mosby-Year Book, Inc., Philadelphia 1995. Ch 7, p 95-113.

Hamer M, Olyarchuk J, Shieh R, Williford D. Relationship of steady state calcium transients to action potential duration in guinea pig ventricular myocytes. Circulation (Supplement III) 82(4):522;1990.

Hamer M, Clair W, Wilkinson W, Greenfield R, Pritchett E, Page R. Evaluation of outpatients with minimally symptomatic shocks from implantable cardioverter defibrillators. PACE 1993:16;943.

Sanders W, Hamer M, Sorrentino R, Greenfield R, Wharton J. Radiofrequency catheter ablation of sinoatrial reentrant tachycardia. PACE 1993:16;850.

Shenasa H, Sanders W, Pressley J, Hamer M, Kanter R, Sorrentino R, Greenfield R, Wharton J. Safety and efficacy of radiofrequency catheter ablation of ectopic atrial tachycardia. PACE 1993:16;850.

Shenasa H, Kanter R, Hamer M, Sorrentino R, Greenfield R, Wharton J. Reappraisal of the efficacy of adenosine for termination of ectopic atrial tachycardia. J Am Coll Cardiol 1993:21(2);456A.

Daubert J, Sorrentino R, Pressley J, Greenfield R, Hamer M, Page R, Wharton J. Prolongation of refractoriness and action potential duration by monophasic and biphasic stimuli in man. J Am Coll Cardiol 1993:21(2);305A.

Shurin PA, Kim CH, Fulton D, and Marchant CD. Susceptibility of Beta-lactamase producing strains of Branhamella catarrhalis to selected, orally administered antimicrobial agents. Proceedings of the Third International Symposium on Recent Advances in Otitis Media with Effusion. In Recent Advances in Otitis Media With Effusion. 1984. Lim, D.J., et. al., eds. Philadelphia, Toronto: B.C. Decker, Inc.

Shlaes DM, Lehman MH, Currie-McCumber CA, Kim CH, and Floyd R. Prevalence of colonization with antibiotic resistant gram-negative bacilli in a nursing home care unit: The importance of cross-colonization as documented by plasmid analysis. Infect Control 1986; 7: 538-45.

Rhinehart E, Shlaes DM, Keyes TF, Serkey J, Kirkley B, Kim CH, Currie-McCumber CA, and Hall G. Nosocomial clonal dissemination of methicillin-resistant Staphylococcus aureus elucidated by plasmid analysis. Arch Intern Med 1987;40: 237-239.

Kim CH, Fan TH, Kelly PF, Himura Y, Delehanty J, Hang CL, Liang CS. Isoform specific regulation of myocardial Na,K-ATPase ?-subunit in congestive heart failure: Role of norepinephrine. Circulation 1994;89:313-20.

Kim CH, Daubert JP, Akiyama T. Antiarrhythmic agents in older patients: Current state of knowledge. Drugs & Aging 1994;4:462-69.

Daubert JP, Kim CH. Nonsustained Ventricular Tachycardia: Current Evaluation and Management. A.N.E. 1997;2(1):79-91.

Aydelotte ME, Kim CH, Akiyama T. Dueling Pacemakers [letter;comment]. Ann Intern Med. 1997;126(8):665

Kim CH, Daubert JP. A Single Center Experience Comparing Thermistor and Thermocouple Ablation Systems. 1997. Submitted for publication.

The AVID Investigators. A Comparison of Antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. NEJM. 1997;337:1576-1583.

Goldstein, BD, Kunis and Rozen. Red cell lipid peroxidation. Abstract ó Blood 48: 963, 1976.

Goldstein, BD, Rozen and Kunis: Role of the red blood cell membrane lipid peroxidation in hemolysis due to phenylhydrazine. Biochem. Pharmacol. 29 (10): 1355-59, 1980

Kunis, RL, Garfein, Pepe and Dwyer. Deglutition syncope and atrioventricular block selectively induced by hot food and liquid. AM. J. Cardiol. 55 (5): 613, 1985.

Kunis, RL, Greenberg, Yeoh, Garfein, Pepe, Pinkernell, Sherrid and Dwyer. Coronary revascularization for recurrent pulmonary edema in elderly patients with ischemic heart disease and preserved ventricular function. N. Engl. J. Med. 313: 1207-10, 1985.

Kunis, RL, Sherrid, Mccabe, Greico and Dwyer. Successful medical therapy of mitral annular abscess complicating infective endocarditis. J. Am. Coll. Cardio. 7: 953-55, 1986

Pearson AC, Peterson JW, Gray P, Binkley PF. Noninvasive Assessment of Aortic Input Impedance in Hypertension (Abstract). Clinical Research 1993; 41:637A.

Peterson JW, Orsinelli DA. Transesophageal Echocardiography: When is it Superior to Standard Imaging in Clinical Practice? Postgraduate Medicine 1995, 97:47-61.

Peterson JW, Guo R, Gray P, Orsinelli DA, Pearson AC. Aging Causes Parallel Remodeling of Descending Thoracic Aorta and Carotid Artery. (Abstract). JACC, February 1994: 101A.

Pearson AC, Peterson JW, Orsinelli DA, et al. Comparison of thickness and distensibility in the carotid artery and descending thoracic aorta: In vivo ultrasound assessment. American Heart Journal 1996; 131:655-62.

Tice FD, Peterson JW, Orsinelli DA, Binkley PF, Cody RJ, Guthrie R, Pearson AC. Vascular hypertrophy is an early finding in essential hypertension and is related to arterial pressure waveform contour. American Heart Journal 1996;132:621-7.

Krishna Rao, A.J. Simons & H. Smulyan. Greenfield Filter Migration in to the Pulmonary Artery; Diagnosis by Trans Esophageal Echocardiography, American Heart Journal . March 1993 (Case Report)

K.K. Sethi, J.C. Mohan, & Krishna Rao. Ventricular Refractorinesis After total Autonomic Blockade (Abstract), PACE. April 1988.

Manoharan, Krishna Rao & U.A. Kaui. Temporary Pacing Associated with Exit Block - Case Report, Journal of Association of Physicians of India. March 1986.

Manoharan Yada Krishna Rao & Khalillullah. Study of the Hemodynamic effects of IV Amrinone in Chronic Congestive Heart Failure. Indian Heart Journal. October 1986.

Cynthia R. Reddeck: Angina & Myocardial Infarction inWomen, in Primary Care of Women. Philadelphia: Lippincott-Raven Publishers, 1997:284-294.

Stuver TP, Hood WM. Jr., "Cyclic AMP independent inotropic abnormalities in the rat infarct heart failure model." Abstract presented at the AHA meeting in March, 1993.

Stuver TP, Cove CJ, Hood WM. Jr., "Downstream defects to cAMP in the rat ischemic heart failure model." Journal of Molecular and Cellular Cardiology. In print.

Stuver TP, Hood WM. Jr., Williford DJ., "The role of calcium in the downstream defect and force-frequency relationship in the rat ischemic heart failure model." Manuscript completed and submitted for publication.

Barold, SS, Falkoff, MD, Ong, LS, Vaughan, MJ, and Heinle, RA: "A-A and V-V Lower Rate Timing of DDD and DDDR Pulse Generators" in New Perspective in Cardiac Pacing 2, Barold, SS, Mugica J (Eds.), Futura Publishing Co., Mt. Kisco, NY, p 203, 1991.

Barold, SS, Falkoff, MD, Ong, LS, Vaughan, MJ, and Heinle, RA: "Atrioventricular Block: New Insights" in New Perspective in Cardiac Pacing 2, Barold, SS, Mugica J (Eds.), Futura Publishing Co., Mt. Kisco, NY, p 23, 1991.

Barold, SS, Falkoff, MD, Ong, LS, Vaughan, MJ, and Heinle, RA: "Atrioventricular Block: in Acute Myocardial Infarction: New Developments" in New Perspective in Cardiac Pacing 2, Barold, SS, Mugica J (Eds.), Futura Publishing Co., Mt. Kisco, NY, p 3, 1991.

Barold, SS, Falkoff, MD, Ong, LS, Vaughan, MJ, and Heinle, RA: "Elective Replacement Indicators of Simple and Complex Pacemakers" in New Perspective in Cardiac Pacing 2, Barold, SS, Mugica J (Eds.), Futura Publishing Co., Mt. Kisco, NY, p 493, 1991.

Barold, SS, Falkoff, MD, Ong, LS, Vaughan, MJ, and Heinle, RA: "Cardiac Pacing in the Nineties. Technologic, Hemodynamic Considerations in the Selection of the Optimal Mode of Pacing" in Challenges in Cardiology 1, Rackley, C (Ed.), Futura Publishing Co., Mt. Kisco, NY, p 39, 1992.

Wiener RS, Finigan MM. "Unprovoked" Respiratory Distress In Young Adult. Hospital Practice 20(6): 110A-110F, 1985.

Wiener RS, Lockhart JT, Schwartz RG. Dilated Cardiomyopathy and Cocaine Abuse. Report of two cases. American Journal of Medicine 81:699-701, 1986.

Wiener RS, Moses HW, Richeson JF, Gatewood RP Jr. Hospital and Long-Term Survival of Acute Pulmonary Edema Associated with Coronary Artery Disease. American Journal of Cardiology 60:33-35, 1987.

Wiener RS, Ong LS. Streptokinase and Splenic Rupture. American Journal of Medicine 86:249, 1989.

Wiener RS, Ong LS. Local Infection After Percutaneous Transluminal Coronary Angioplasty: Relation To Early Repuncture of Ipsilateral Femoral Artery. Catheterization and Cardiovascular Diagnosis 16:180-181, 1989.

Kerr J, Ramamurthy G, Botros E, Dolan JG, Thomas JL, Wiener R. Diagnostic Approach to Chest Pain Syndrome in Women. Journal of Clinical Outcomes Management 5:57-72, 1998.

Zain S, Wiener R. Gene Structure: Its Expression and Function in Eukarvotes. Proceedings of the International Symposium on New Researches in Biology and Genetics (ed. Said HM), Hamdard Academy, 1979 pp. 259-270.

Kass RS, Arena JP, Wiener RS. Membrane Potential and Nisoldipine Block of Calcium Channels in the Heart: Interactions with Channel Gating. Nisoldpine 1987 (eds. Hugenholtz PG, Meyer J.). Springer-Verlag, 1987, pp. 13-26.